Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Bullboard Posts
Comment by NeedAPoolon Sep 15, 2020 9:14am
153 Views
Post# 31559002

RE:RE:Checkout news update.....

RE:RE:Checkout news update.....The devil is in the details. Where does it say that Health Canada is fast tracking THRM? There are three things stated in that paragraph:

1. THRM has been in contact with HC with regards to the PROCESS for regulatory approval. NOT in discussion with them about their product, in discussion with them so they know the steps that have to be followed in order to get approval. 
2. It states that HC was given approval to fast track Covid related products. This doesn't single out THRM, it's a generic comment.
3. It states that under this order, CoviSafe WILL be eligible for for expedited review.

I'm not being negative about THRM. I think this is going to make me a lot of money in the short to mid-term. I'm pointing out how misleading your post is. THRM is essentially telling us the route they are going to follow in order to get approval. If you feel I am not on track with my assessment, read the first sentence of the next paragraph... "The initial application of the CoviSafe™ test will be for symptomatic patients and administered by health care professionals."

There is enough good going on with this stock without the need to mislead.
Bullboard Posts